Advertisement

Topics

AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies

11:06 EDT 16 Apr 2018 | ecancermedicalscience

FT819, an off-the-shelf, T-cell receptor (TCR)-less CD19 CAR T-cell product that could potentially be made more accessible to cancer patients than conventional CAR T-cell therapies showed positive results in preclinical specificity, functionality, and...

Original Article: AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies

NEXT ARTICLE

More From BioPortfolio on "AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...